Predictive Biomarker of Chemotherapeutic Response in Osteosarcoma Found
Expression of a specific protein in patients with osteosarcoma can help predict response to neoadjuvant chemotherapy.
Expression of a specific protein in patients with osteosarcoma can help predict response to neoadjuvant chemotherapy.
The largest Phase 2 study in patients with chordoma to date “confirms anecdotal evidence that imatinib has antitumor activity in this orphan disease, and therefore, it is worth further investigation,” according to a study in the Journal of Clinical Oncology.
Many adults aged 75 years or older routinely undergo cancer screening.
Overall cancer rates have decreased for men and remained stable for women, but mortality from cancer has declined for both men and women, according to a report from the American Cancer Society.